drugset / Trial / NCT01350921

Evaluation of the Drug-drug Interaction Between Ticagrelor and Venlafaxine When Taken Together in Healthy Volunteers

NCT01350921

Phase 1 Completed 22 enrolled AstraZeneca
CrossoverOpen-labelBasic science

Summary

Study evaluates the drug-drug interaction between Ticagrelor and Venlafaxine when taken together in healthy volunteers

Timeline

Start
2011-05
Primary completion
2012-03
Completion
2012-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Ticagrelor Small molecule 90 mg Oral
Subject Venlafaxine Small molecule 37.5 mg Oral

Indications

No indication recorded.